Literature DB >> 8765002

Salvage of catabolic products in ganglioside metabolism: a study on rat cerebellar granule cells in culture.

L Riboni1, R Bassi, A Prinetti, G Tettamanti.   

Abstract

Cerebellar granule cells in culture were subjected to a pulse (0.5-4 h)-chase (0-4 h) of 10(-6) M [3H]ganglioside GM1 carrying the radioactive label at the level of NeuAc ([3H-NeuAc]GM1), Sph ([3H-Sph]GM1) or Gal ([3H-Gal]GM1) and the formed [3H]metabolites were determined. With all forms of [3H]GM1, there was formation of [3H]catabolites, including [3H]H2O and [3H]biosynthetic products obtained by recycling of [3H]NeuAc, [3H]Sph and [3H]Gal released during intralysosomal ganglioside degradation (salvage processes). Much higher amounts of [3H]H2O were produced from [3H-Gal]GM1 than [3H-Sph]GM1 and [3H-NeuAc]GM1; conversely, more products from salvage processes (polysialogangliosides GD1a, GD1b, GT1b, O-acetylated GT1b, protein-bound radioactivity) were obtained with [3H-NeuAc]GM1 than the two other forms of [3H]GM1. Liberated [3H]NeuAc produced 10-fold less tritiated water and 10-fold higher salvage products than [3H]Gal. Using [3H-NeuAc]GM1, granule cells appeared to metabolize 7.7% of membrane-incorporated exogenous GM1 per hour with a high degree of NeuAc recycling and the calculated metabolic half-life was 6.5 h.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8765002     DOI: 10.1016/0014-5793(96)00772-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons.

Authors:  C A Stern; M Tiemeyer
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

2.  Predominance of the acylation route in the metabolic processing of exogenous sphingosine in neural and extraneural cells in culture.

Authors:  L Riboni; R Bassi; A Prinetti; P Viani; G Tettamanti
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

3.  Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons.

Authors:  Nadine Hagen-Euteneuer; Dieter Lütjohann; Hyejung Park; Alfred H Merrill; Gerhild van Echten-Deckert
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

4.  Metabolic formation of ceramide-1-phosphate in cerebellar granule cells: evidence for the phosphorylation of ceramide by different metabolic pathways.

Authors:  Laura Riboni; Rosaria Bassi; Viviana Anelli; Paola Viani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

5.  Efflux of sphingolipids metabolically labeled with [1-3H]sphingosine, L-[3- 3H]serine and [9,10- 3H]palmitic acid from normal cells in culture.

Authors:  Vanna Chigorno; Mariateresa Sciannamblo; Joanna Mikulak; Alessandro Prinetti; Sandro Sonnino
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

Review 6.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

7.  Glycosphingolipids.

Authors:  Elena Chiricozzi; Massimo Aureli; Laura Mauri; Erika Di Biase; Giulia Lunghi; Maria Fazzari; Manuela Valsecchi; Emma Veronica Carsana; Nicoletta Loberto; Alessandro Prinetti; Sandro Sonnino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 8.  Ganglioside/glycosphingolipid turnover: new concepts.

Authors:  G Tettamanti
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 9.  Synthesis of radioactive and photoactivable ganglioside derivatives for the study of ganglioside-protein interactions.

Authors:  Laura Mauri; Simona Prioni; Nicoletta Loberto; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.